Skip to main content
Y

YungShin Global Holding Corporation — Investor Relations & Filings

Ticker · 3705 TW Financial and insurance activities
Open in API
Filings indexed 2,125 across all filing types
Latest filing 2026-03-31 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 3705

About YungShin Global Holding Corporation

https://www.yungshingroup.com

YungShin Global Holding Corporation is an investment holding company focused on the pharmaceutical and comprehensive healthcare sectors. Through its subsidiaries, the group manages an integrated value chain that spans research and development, manufacturing, and global distribution. Its diverse product portfolio includes human prescription and over-the-counter generic medicines, active pharmaceutical ingredients (APIs), animal health products, and health supplements. The company also provides cosmetics and specialty chemicals. Leveraging advanced enterprise resource planning systems to ensure operational transparency and quality control, the group serves a broad international market. Its core mission centers on delivering holistic health solutions and maintaining a robust presence across the healthcare supply chain, supported by a long-standing commitment to social welfare and community health initiatives.

Recent filings

Filing Released Lang Actions
114年第4季綜合損益表
Interim / Quarterly Report Classification · 1% confidence The document is a consolidated statement of comprehensive income (合併綜合損益表) provided by a company (永信) via the Taiwan Stock Exchange's Market Observation Post System (公開資訊觀測站). It contains detailed financial data for the 4th quarter of the 114th year (Republic of China calendar), including revenue, operating costs, expenses, net income, and earnings per share. Since it provides comprehensive financial statements for a specific quarterly period rather than just a summary or an announcement, it is classified as an Interim/Quarterly Report. Q4 2025
2026-03-31 Chinese
114年第4季資產負債表
Interim / Quarterly Report Classification · 1% confidence The document is a Consolidated Balance Sheet (合併資產負債表) provided by a company (永信公司) for the 4th quarter of the 114th fiscal year. It contains detailed financial line items, comparative data for the previous year, and specific accounting classifications. Since it provides substantive financial statements for a quarterly period, it is classified as an Interim/Quarterly Report (IR). Q4 2025
2026-03-31 Chinese
更正本公司114年度合併財報之IXBRL申報資訊
Regulatory Filings Classification · 1% confidence The document is a short announcement filed on the Taiwan ‘公開資訊觀測站’ (MOPS) notifying investors of a correction to the company’s previously filed 114th annual consolidated financial report (IXBRL data). It does not contain the full financial statements themselves (so it is not an Annual Report or Interim Report), nor is it a dividend, board change, or other specific transaction notice. It simply provides corrected figures and states that the revised report has been re-uploaded. This fits the ‘Regulatory Filings’ fallback category for miscellaneous regulatory announcements that do not fall under a more specific form. Therefore, it should be classified as RNS.
2026-03-31 Chinese
114年第4季海外子公司投資
Regulatory Filings
2026-03-31 Chinese
114年度財務比率
Regulatory Filings
2026-03-31 Chinese
董事會決議股利分派
Regulatory Filings
2026-03-25 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.